• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Nasopharyngeal carcinoma - Improving cure with technology and clinical trials.鼻咽癌——借助技术与临床试验提高治愈率。
World J Otorhinolaryngol Head Neck Surg. 2020 Apr 15;6(1):1-3. doi: 10.1016/j.wjorl.2020.03.001. eCollection 2020 Mar.
2
Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma.挽救性鼻内镜下鼻咽癌切除术联合调强放疗与传统放疗治疗局部复发性鼻咽癌的比较
Head Neck. 2015 Aug;37(8):1108-15. doi: 10.1002/hed.23719. Epub 2014 Jul 11.
3
Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma.洛铂联合多西他赛新辅助化疗，随后洛铂与调强放疗同步进行，可提高高危淋巴结阳性鼻咽癌患者的生存率。
J BUON. 2016 Jan-Feb;21(1):161-7.
4
Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.尼妥珠单抗联合新辅助化疗后序贯同步放化疗治疗局部晚期鼻咽癌的疗效和安全性
Oncotarget. 2017 Apr 21;8(43):75544-75556. doi: 10.18632/oncotarget.17357. eCollection 2017 Sep 26.
5
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌新辅助化疗后同期放化疗与同期放化疗后辅助化疗的比较。
BMC Cancer. 2018 Mar 27;18(1):329. doi: 10.1186/s12885-018-4210-3.
6
Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.采用调强放疗联合每周一次顺铂同步治疗，加或不加新辅助化疗，治疗局部区域晚期鼻咽癌。
Radiat Oncol J. 2015 Jun;33(2):98-108. doi: 10.3857/roj.2015.33.2.98. Epub 2015 Jun 30.
7
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.新辅助化疗联合调强放疗与同步放化疗联合辅助化疗治疗局部晚期鼻咽癌的回顾性对照研究
Chin J Cancer. 2016 Jan 6;35:2. doi: 10.1186/s40880-015-0076-9.
8
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.诱导化疗加同期放化疗对比单纯同期放化疗治疗局部晚期鼻咽癌：一项 3 期、多中心、随机对照临床试验。
Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27.
9
Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.调强放射治疗时代基于顺铂的同步化疗在低危鼻咽癌中的倾向评分匹配分析
Oncotarget. 2015 Dec 22;6(41):44019-29. doi: 10.18632/oncotarget.5806.
10
Concurrent Chemoradiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma: Treatment Outcomes and Prognostic Factors.局部晚期鼻咽癌同步放化疗：治疗结果与预后因素
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1591-1599. doi: 10.22034/APJCP.2018.19.6.1591.

引用本文的文献

1
Dehydrocrenatidine extracted from induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways.从杠柳中提取的去氢杠柳堿通过 JNK 和 ERK 信号通路诱导鼻咽癌细胞凋亡。
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8117. Epub 2021 Jun 24.

本文引用的文献

1
Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison.调强碳离子放射治疗与调强光子放射治疗在局部复发性鼻咽癌中的剂量学比较
Cancer Manag Res. 2019 Aug 16;11:7767-7777. doi: 10.2147/CMAR.S205421. eCollection 2019.
2
Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG.明确调强放疗后鼻咽癌局部复发的治疗模式和治疗效果：来自 HKNPCSG 的研究。
Head Neck. 2019 Oct;41(10):3661-3669. doi: 10.1002/hed.25892. Epub 2019 Jul 27.
3
Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.质子治疗复发性鼻咽癌的临床结果。
Acta Oncol. 2019 Sep;58(9):1238-1245. doi: 10.1080/0284186X.2019.1622772. Epub 2019 Jun 3.
4
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.吉西他滨和顺铂诱导化疗治疗鼻咽癌。
N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31.
5
Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.碳离子放疗挽救治疗局部复发鼻咽癌患者的初步结果。
Cancer. 2018 Jun 1;124(11):2427-2437. doi: 10.1002/cncr.31318. Epub 2018 Mar 26.
6
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.帕博利珠单抗治疗程序性死亡配体 1 阳性鼻咽癌患者的安全性和抗肿瘤活性：KEYNOTE-028 研究结果。
J Clin Oncol. 2017 Dec 20;35(36):4050-4056. doi: 10.1200/JCO.2017.73.3675. Epub 2017 Aug 24.
7
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.血浆 Epstein-Barr 病毒 DNA 分析用于筛查鼻咽癌。
N Engl J Med. 2017 Aug 10;377(6):513-522. doi: 10.1056/NEJMoa1701717.
8
Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.调强质子治疗鼻咽癌：减少对正常组织的辐射剂量并取得令人鼓舞的临床结果。
Head Neck. 2016 Apr;38 Suppl 1:E1886-95. doi: 10.1002/hed.24341. Epub 2015 Dec 26.
9
Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma – A case-matched comparison.挽救性鼻内镜下鼻咽癌切除术在治疗特定T1-T3期鼻咽癌局部复发方面优于调强放射治疗——一项病例匹配比较研究
Radiother Oncol. 2015 Jun;115(3):399-406. doi: 10.1016/j.radonc.2015.04.024. Epub 2015 May 16.
10
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.NPC-0501试验的初步结果，该试验评估了局部晚期鼻咽癌患者从同步辅助放化疗改为诱导-同步放化疗、从氟尿嘧啶改为卡培他滨以及从常规放疗分割改为加速放疗分割后的治疗获益情况。
Cancer. 2015 Apr 15;121(8):1328-38. doi: 10.1002/cncr.29208. Epub 2014 Dec 19.

Nasopharyngeal carcinoma - Improving cure with technology and clinical trials.

作者信息

Tsang Raymond K

机构信息

Division of Otolaryngology, Department of Surgery, University of Hong Kong, Hong Kong, China.

出版信息

World J Otorhinolaryngol Head Neck Surg. 2020 Apr 15;6(1):1-3. doi: 10.1016/j.wjorl.2020.03.001. eCollection 2020 Mar.

DOI:10.1016/j.wjorl.2020.03.001
PMID:32426697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7221204/
Abstract
摘要